ZURICH, Oct 25 (Reuters) - Novartis'(NOVN.VX) chairman Daniel Vasella was elected board chairman of Alcon (ACL.N), increasing the Swiss drugmaker’s grip of the U.S. eyecare company as it tries to buy the stake it does not already own.
ZURICH, Oct 25 (Reuters) - Novartis'(NOVN.VX) chairman Daniel Vasella was elected board chairman of Alcon (ACL.N), increasing the Swiss drugmaker’s grip of the U.S. eyecare company as it tries to buy the stake it does not already own.
